Two Sigma Investments’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,711
Closed -$916K 3176
2024
Q1
$916K Sell
14,711
-8,383
-36% -$544K ﹤0.01% 2003
2023
Q4
$1.33M Buy
23,094
+13,794
+148% +$706K ﹤0.01% 1898
2023
Q3
$437K Sell
9,300
-30,961
-77% -$1.55M ﹤0.01% 2334
2023
Q2
$1.79M Buy
40,261
+16,111
+67% +$572K ﹤0.01% 1514
2023
Q1
$512K Buy
+24,150
New +$538K ﹤0.01% 2192
2021
Q4
Sell
-1,316
Closed -$160K 4556
2021
Q3
$160K Buy
1,316
+839
+176% +$115K ﹤0.01% 4011
2021
Q2
$93K Buy
+477
New +$157K ﹤0.01% 3907

Other funds holding IRON

Two Sigma Investments's IRON Position: Q2 2024 in Review

Two Sigma Investments sold out of Disc Medicine (IRON) in Q2 2024, closing a stake of 14,711 shares — an estimated $916K sold.

Two Sigma Investments first reported a position in IRON in Q2 2021 and held it in 7 quarters. The position peaked at $1.79M in Q2 2023. 121 funds tracked by Wall St. Rank hold IRON as of Q2 2024.

  • Two Sigma Investments reported no remaining Disc Medicine position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Investments sold 14,711 Disc Medicine shares in Q2 2024, an estimated $916K.
  • Two Sigma Investments first reported a position in Disc Medicine in Q2 2021 and held it in 7 quarters.
  • Two Sigma Investments's Disc Medicine position peaked at $1.79M in Q2 2023.
  • 121 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2024.

Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.